Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

784 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Recruiting

Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A

NCT04131036

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Orthopedic Hemophilia Treatment Center Los Angeles, California, United States
  • Hemophilia and Thrombosis Treatment Center, University of California, San Diego San Diego, California, United States
  • The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
  • Washington Center for Bleeding Disorders at Washington Institute for Coagulation Seattle, Washington, United States
View Trial Details
Recruiting

Embolization in Hereditary Coagulopathies

NCT05629130

Conditions
Arthropathy, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +17 more
Locations
  • Instituto de Ortopedia e Traumatologia do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo, Brazil
View Trial Details
Enrolling by Invitation

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

NCT06831734

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Chiba university hospital_Pediatrics Chiba, Japan
  • National Hospital Organization Awara Hospital_Hematology and Oncology Fukui, Japan
  • Hoshi General Hospital_Pediatrics Fukushima, Japan
  • Hyogo Prefectural Amagasaki General Medical Center_Haematology Hyōgo, Japan
View all 23 locations
View Trial Details
Enrolling by Invitation

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

NCT06285071

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Novo Nordisk Investigational Site Toshima City, Tokyo, Japan
  • Mutsu general hospital_Pediatrics Aomori, Japan
  • Kyushu university hospital_Pediatrics Fukuoka, Japan
  • Sapporo Tokushukai Hospital_Pediatrics Hokkaido, Japan
View Trial Details
Enrolling by Invitation

A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

NCT03745924

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • AKH - Klin. Abt. f. Haematologie u. Haemostaseologie Vienna, Austria
  • Cliniques universitaires Saint-Luc - Service Hématologie Brussels, Belgium
  • UZ Antwerpen - UZA - Kinderhemato-Oncologie Edegem, Belgium
  • UZ Leuven - Hart en Vaatziekten Leuven, Belgium
View all 30 locations
View Trial Details

Related conditions